Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/35066
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorSchool of Nursing-
dc.creatorChien, WT-
dc.creatorMui, J-
dc.creatorGray, R-
dc.creatorCheung, E-
dc.date.accessioned2016-03-21T03:23:22Z-
dc.date.available2016-03-21T03:23:22Z-
dc.identifier.urihttp://hdl.handle.net/10397/35066-
dc.language.isoenen_US
dc.publisherBioMed Central Ltd.en_US
dc.rights© 2016 Chien et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en_US
dc.subjectAdherence therapyen_US
dc.subjectAntipsychoticsen_US
dc.subjectMotivational interviewingen_US
dc.subjectRandomised controlled trialen_US
dc.subjectSchizophreniaen_US
dc.subjectInsight into treatmenten_US
dc.titleAdherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders : a randomised controlled trialen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.doi10.1186/s12888-016-0744-6en_US
dcterms.abstractBackground: Current practice guidelines for schizophrenia care recommend that antipsychotic medication is essential for patients’ long-term maintenance treatment but their non-adherence to this medication is still a main obstacle to relapse prevention. This study evaluated the effects of a motivational-interviewing-based adherence therapy for people with schizophrenia spectrum disorders.-
dcterms.abstractMethods: This randomised controlled trial was conducted with 134 outpatients with schizophrenia spectrum disorders; 67 of them received a six-session adherence therapy (in addition to usual care) and 67 received usual psychiatric care alone. Participants’ outcome measures included symptom severity, medication adherence, hospitalisation rates, insight into illness/treatment, and functioning.-
dcterms.abstractResults: The adherence therapy group reported significantly greater improvements in symptom severity (p < 0.003), insight into illness/treatment (p < 0.001), functioning (p < 0.005), duration of re-hospitalisations (p < 0.005), and medication adherence (p < 0.005) over 18 months follow-up, when compared with usual care alone.-
dcterms.abstractConclusions: Motivational-interviewing-based adherence therapy can be an effective approach to treatment for people with early stage of schizophrenia who poorly adhere to medication regimen. Trial registration: ClinicalTrials.gov NCT01780116, registration date January 29, 2013.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationBMC psychiatry, 2016, v. 16:42, p. 1-14-
dcterms.isPartOfBMC psychiatry-
dcterms.issued2016-02-25-
dc.identifier.eissn1471-244Xen_US
dc.identifier.rosgroupid2015000100-
dc.description.ros2015-2016 > Academic research: refereed > Publication in refereed journalen_US
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_IR/PIRAen_US
dc.description.pubStatusPublisheden_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Chien_Adherence_Therapy_Routine.pdf1.57 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

290
Last Week
1
Last month
Citations as of Mar 24, 2024

Downloads

133
Citations as of Mar 24, 2024

SCOPUSTM   
Citations

31
Last Week
0
Last month
Citations as of Mar 29, 2024

WEB OF SCIENCETM
Citations

30
Last Week
0
Last month
Citations as of Mar 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.